CMV-infection in patients after liver transplantation

CMV-infection in patients after liver transplantation

The article presents an analysis of the current state of the problem antiviral therapy CMV-infection in patients undergoing liver transplantation. We retrospectively reviewed the experience of the Moscow Center for liver transplantation in the prevention of cytomegalovirus disease in liver recipient...

Full description

Saved in:

Bibliographic Details
Main Authors:	M. Sh. Khubutiya, V. E. Syutkin, A. A. Salienko, M. S. Novruzbekov
Format:	Article
Language:	English
Published:	N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department 2016-02-01
Series:	Трансплантология (Москва)
Subjects:	transplantation of the liver cmv-infection (val-)ganciclovir
Online Access:	https://www.jtransplantologiya.ru/jour/article/view/41
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cytomegalovirus mismatch after heart transplantation: Impact of antiviral prophylaxis and intravenous hyperimmune globulin
by: Moritz B. Immohr, et al.
Published: (2021-12-01)

Progress and Challenges in the Management of Congenital Cytomegalovirus Infection
by: Weronika Szulc, et al.
Published: (2024-11-01)

The use of sofosbuvir for the treatment of recurrent hepatitis C after liver transplantation
by: M. Sh. Khubutiya, et al.
Published: (2017-03-01)

Clinical and Economic Burden Associated With Anti-Cytomegalovirus (CMV) Prophylaxis Therapies in Adult Kidney Transplant Recipients (LECOCYT): An Observational Study
by: Nassim Kamar, et al.
Published: (2025-05-01)

Tackling CMV in Transplant Recipients: Past, Present, and Future
by: Tal Schlaeffer-Yosef, et al.
Published: (2025-04-01)

Discordance between humoral and cellular immune responses to cytomegalovirus infection in CMV seropositive patients awaiting lung transplantation
by: Meritxell Boada-Pérez, et al.
Published: (2025-01-01)

Effector-Memory γδ T Lymphocytes Predict CMV Disease After the Withdrawal of Prophylaxis in Kidney Transplant Recipients
by: Yoann Abadie, et al.
Published: (2025-07-01)

An impact of CMV and HHV-6 reactivation on the course of early period after hematopoietic stem cell transplantation in patients with hematologic malignancies
by: T. V. Antonova, et al.
Published: (2023-01-01)

Relapse of autoimmune diseases after liver transplantation
by: V. E. Syutkin, et al.
Published: (2022-12-01)

The use of telaprevir for the treatment of hepatitis C in patients undergoing liver transplantation (Literature review and clinical experience)
by: M. Sh. Khubutiya, et al.
Published: (2016-02-01)

Co-infection of cytomegalovirus and Leishmania without splenomegaly resulting in immunosuppression in an HIV-negative patient
by: Inder Preet Singh Bhatia, et al.
Published: (2024-10-01)

Experience of using anidulafungin for treatment of invasive candidosis in patients after liver transplantation
by: M. Sh. Khubutiya, et al.
Published: (2016-02-01)

Investigation of Pre- and Postnatal Abnormalities Caused by Prenatal CMV Infection—Systematic Review
by: Virág Bartek, et al.
Published: (2025-05-01)

Treatment of the «intra-abdominal infection» after orthotopic liver transplantation (a case report)
by: M. Sh. Khubutia, et al.
Published: (2018-08-01)

Congenital cytomegalovirus infection: new answers to old problems
by: Ya. R. Khizhak, et al.
Published: (2024-06-01)

Prevention of fungal infection in the early period after liver transplantation
by: M. Sh. Khubutiya, et al.
Published: (2016-06-01)

Evaluation of cytomegalovirus infection/disease in IgG positive renal transplantation recipients on valaciclovir prophylaxis
by: Tugba Sari, et al.
Published: (2022-12-01)

Cytomegalovirus reactivation following hematopoietic stem cell transplantation
by: Sanjeev Kumar Sharma, et al.
Published: (2013-12-01)

DIFFERENT COURSES OF HBV INFECTION AFTER LIVER TRANSPLANTATION
by: V. E. Syutkin, et al.
Published: (2011-06-01)

Changes in glomerular filtration rate in liver recipients after reduced exposure to calcineurin inhibitors with concomitant everolimus administration within the first year after immunosuppression conversion
by: V. E. Syutkin, et al.
Published: (2022-01-01)

ORAI1 defect in a patient with disseminated CMV infection and severe hypotonia
by: Kübra Deveci, et al.
Published: (2023-08-01)

Infection risk after paediatric liver transplantation
by: Mukadder Ayşe Selimoğlu, et al.
Published: (2020-02-01)

Surveillance over cytomegalovirus (CMV) reactivation following hematopoietic stem cell transplantation: a single-center experience
by: Zhivka Stoykova, et al.
Published: (2024-12-01)

Risk factors affecting the incidence of CMV infection in recipients after living donor liver transplantation
by: Mostafa Attya Elfors, et al.
Published: (2025-06-01)

Biomarkers of tolerance and immunological monitoring in liver transplantation
by: V. E. Syutkin, et al.
Published: (2020-06-01)

Complete regression of generalized plasmacytoma of lymph nodes in a liver transplant recipient during the conversion of immunosuppressive therapy from tacrolimus to everolimus
by: V. E. Syutkin, et al.
Published: (2021-09-01)

CMV infection prevention during pregnancy: a call for effective and sustained educational efforts
by: Joshua Sohmer, et al.
Published: (2025-08-01)

Seroprevalence of IgM antibodies against cytomegalovirus (CMV) in HIV patients: single center study
by: Deema I Fallatah, et al.
Published: (2025-04-01)

Young Kidney-Transplant Recipient Woman with Recurrent Urinary Tract Infection and Graft Rejection: A Case Repor
by: Nursamsu, et al.
Published: (2019-12-01)

The effect of early everolimus administration on the renal function while reducing the dosage of calcineurin inhibitors in liver transplant recipients in a long-term follow-up
by: V. E. Syutkin, et al.
Published: (2021-06-01)

Transplantation of organs from donors infected with blood-borne viral infections. The experience of foreign countries
by: M. Sh. Khubutiya, et al.
Published: (2016-12-01)

CMV Retinitis in the Context of SARS-CoV-2 Infection: A Case Study and Comprehensive Review of Viral Interactions
by: Emil Robert Stoicescu, et al.
Published: (2024-10-01)

Monitoring of the redox potential of blood serum for the diagnosis of complications in patients with liver transplants
by: M. Sh. Khubutiya, et al.
Published: (2018-08-01)

Reliability of CMV-IgG kinetics in the diagnosis of CMV primary infection: sensitivity, specificity, and clinical implications
by: Vincent Portet Sulla, et al.
Published: (2025-08-01)

Transplant centers’ prophylaxis and monitoring strategies: a key determinant of current herpes and polyomavirus incidences – results from the DZIF kidney transplant cohort
by: Claudia Sommerer, et al.
Published: (2025-04-01)

Treatment of hepatitis C in liver transplant recipients in the Moscow Center for Liver Transplantation within 10 years
by: M. Sh. Khubutia, et al.
Published: (2016-01-01)

Misleading Diagnosis of Radiological Imaging of COVID-19 Pneumonia During Pandemic Era: Risk on the Existence of CMV Infection
by: Ceva Wicaksono Pitoyo, et al.
Published: (2020-12-01)

Misleading Diagnosis of Radiological Imaging of COVID-19 Pneumonia During Pandemic Era: Risk on the Existence of CMV Infection
by: Ceva Wicaksono Pitoyo, et al.
Published: (2020-12-01)

Screening among Pregnant Women for Cytomegalovirus (CMV) Infection — Recommendations in Poland and Selected Countries Worldwide (a Preliminary Study to Investigate the Incidence of Neurological Complications in CMV — Infected Children)
by: Adrianna Frydrysiak-Brzozowska, et al.
Published: (2022-06-01)

Impact of viral load kinetics and recurrent cytomegalovirus infection in kidney transplantation
by: Sabina Dobrer, et al.
Published: (2025-08-01)